These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 341948

  • 1. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S, Cronholm B, Asberg M, Montgomery DB.
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [Abstract] [Full Text] [Related]

  • 2. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C, von Zerssen D.
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [Abstract] [Full Text] [Related]

  • 3. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP, Ferreira L, Abreu-Lima C, Ramalhão C, Fernandes R.
    Clin Ther; 1985 Nov; 7(5):584-92. PubMed ID: 3902238
    [Abstract] [Full Text] [Related]

  • 4. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP.
    Postgrad Med J; 1977 Nov; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract] [Full Text] [Related]

  • 5. Three double-blind comparative trials of mianserine (ORG GB 94) and amitriptyline in the treatment of depressive illness.
    Jaskari MO, Ahfors UG, Ginman L, Lydekcne K, Tienari P.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):101-3. PubMed ID: 360231
    [Abstract] [Full Text] [Related]

  • 6. A comparison of maprotiline and amitriptyline in the treatment of depression in general practice.
    Silverstone JT, Carne HJ, Dell A, Franklin CJ, Singer R, Swirsky SN, Forrest WA.
    Practitioner; 1977 Feb; 218(1304):279-82. PubMed ID: 320594
    [No Abstract] [Full Text] [Related]

  • 7. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T.
    Clin Ther; 1981 Feb; 3(5):374-81. PubMed ID: 7471133
    [Abstract] [Full Text] [Related]

  • 8. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W, Pöldinger W.
    Int Pharmacopsychiatry; 1977 Feb; 12(2):65-71. PubMed ID: 330440
    [Abstract] [Full Text] [Related]

  • 9. Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
    Mulgirigama LD, Pare CM, Turner P, Wadsworth J, Witts DJ.
    Postgrad Med J; 1977 Feb; 53 Suppl 4():155-9. PubMed ID: 341104
    [No Abstract] [Full Text] [Related]

  • 10. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
    Okasha A, Sadek A.
    J Egypt Med Assoc; 1976 Feb; 59(5-6):557-62. PubMed ID: 801741
    [No Abstract] [Full Text] [Related]

  • 11. Mianserin versus amitriptyline. A double-blind-trial evaluated by the AMP system.
    Vogel HP, Bente D, Feder J, Helmchen H, Müller-Oerlinghausen B, Bohacek N, Mihovilović M, Brändli A, Fleischhauer J, Walcher W.
    Int Pharmacopsychiatry; 1976 Feb; 11(1):25-31. PubMed ID: 770364
    [Abstract] [Full Text] [Related]

  • 12. Mianserin in the treatment of depressive illness: a comparison with amitriptyline.
    Daly RJ, Browne PJ, Morgan E.
    Ir J Med Sci; 1979 Apr; 148(4):145-8. PubMed ID: 393652
    [No Abstract] [Full Text] [Related]

  • 13. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC, Logothetis JA, Paschalidou M.
    Adv Biochem Psychopharmacol; 1982 Apr; 32():213-22. PubMed ID: 7046365
    [Abstract] [Full Text] [Related]

  • 14. A comparison of maprotiline (Ludiomil) and amitriptyline (1).
    Dell AJ.
    J Int Med Res; 1977 Apr; 5 Suppl 4():22-4. PubMed ID: 338398
    [Abstract] [Full Text] [Related]

  • 15. A comparison of maprotiline (Ludiomil) and amitriptyline (2).
    Mindham BA.
    J Int Med Res; 1977 Apr; 5 Suppl 4():25-33. PubMed ID: 338399
    [Abstract] [Full Text] [Related]

  • 16. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
    Edwards JG, Goldie A.
    Br J Clin Pharmacol; 1983 Apr; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
    [Abstract] [Full Text] [Related]

  • 17. Proceedings: Mianserin vs. amitriptyline--a double-blind-trial evaluated by the AMP-system.
    Vogel HP, Bente D, Feder J, Helmchen H, Müller-Oerlinghausen B, Bohacek N, Mihovilovic M, Brändle A, Fleischhauer J, Walcher W.
    Act Nerv Super (Praha); 1975 Apr; 17(4):229-30. PubMed ID: 769477
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA, McAuley R, Montgomery DB, Dawling S, Braithwaite RA.
    Clin Ther; 1980 Apr; 3(4):292-310. PubMed ID: 7023677
    [No Abstract] [Full Text] [Related]

  • 19. Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline.
    Branconnier RJ, Cole JO, Ghazvinian S, Rosenthal S.
    Adv Biochem Psychopharmacol; 1982 Apr; 32():195-212. PubMed ID: 7046364
    [Abstract] [Full Text] [Related]

  • 20. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A, Orefice G, Carrieri P.
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.